Pharmacy and Pharmaceutical Sciences Commons^™

Optimizing Collaboration Among Clinical Pharmacy Specialists And Behavioral Health Providers In The Primary Care Setting To Increase Mental Health Access, Ryan Ferris, Christine Doran, Bonnie Jiron, Dara L. Johnson

Providence Pharmacy PGY2 Program at Providence Medical Group 2023

No abstract provided.

Dalbavancin Utilization And Associated Clinical Outcomes Within A Large, Integrated Health System, Meagan Greckel, Brent Footer

Providence Pharmacy PGY2 Program at Providence Medical Group 2022

No abstract provided.

Implementation And Evaluation Of A Post-Discharge Clinical Patient Follow-Up Service In A Health System Outpatient Pharmacy Setting, Erin Wu, Adam Saulles, Amber Franck, Ryan Bradley

Providence Pharmacy PGY1 Program at Providence Portland and Providence St. Vincent Medical Centers 2022

No abstract provided.

Standardized Pharmacist Led Medication Review In Patients With Recent Falls, Christopher Houpt, Natsuki Kubotera

Providence Pharmacy PGY2 Program at Providence Medical Group 2022

No abstract provided.

Evaluation Of Specialty Pharmacy Productivity Metrics To Create An Updated Standardized Productivity Tool, David Kim, Adam Saulles, Ryan Bradley

Providence Pharmacy PGY1 Program at Providence Portland and Providence St. Vincent Medical Centers 2022

No abstract provided.

Prescribing Patterns Of Antipsychotics For Agitation Or Delirium Management In Non-Critically Ill Patients, Emily Chang, Pamela Levine

Providence Pharmacy PGY1 Program at Providence Portland and Providence St. Vincent Medical Centers 2022

No abstract provided.

Rifaximin (Xifaxan) Therapy Initiation During Hospitalization And Access Facilitation At Discharge, Phuong Phan, Theresa Morikawa, Adam Saulles

Providence Pharmacy PGY1 Program at Providence Portland and Providence St. Vincent Medical Centers 2022

No abstract provided.

Fixed-Dose Prothrombin Complex Concentrate Versus Weight-Based Dose For Reversal Of Factor Xa Inhibitors, Kevin Chau, Bryce Winn, Peter Martsin

Providence Pharmacy PGY1 Program at Providence Portland and Providence St. Vincent Medical Centers 2022

No abstract provided.

Tenecteplase Implementation For Ischemic Stroke At A Large Tertiary Medical Center, Laura Kays, Bryce Winn, Aimee Doyle

Providence Pharmacy PGY1 Program at Providence Portland and Providence St. Vincent Medical Centers 2022

No abstract provided.

Evaluating The Impact Of A Pharmacist Run Pharmacotherapy Service On Hepatitis C Outcomes In A Large Integrated Health-System, Jessica Hendrix, Charmaine Hunt, Judy Perkins

Providence Pharmacy PGY1 Program at Providence Portland and Providence St. Vincent Medical Centers 2022

No abstract provided.

Evaluation Of An Outpatient Pharmacy Collaboration With A Hospital Quality Initiative To Increase Access To Naloxone At Hospital Discharge, Melissa Yokoyama, Theresa Morikawa, Amber Franck, Adam Saulles

Providence Pharmacy PGY1 Program at Providence Portland and Providence St. Vincent Medical Centers 2022

No abstract provided.

Evaluation Of A Discharge Medication Access Service Program At Two Large Tertiary Medical Centers, Eva Huang, Theresa Morikawa, Adam Saulles

Providence Pharmacy PGY1 Program at Providence Portland and Providence St. Vincent Medical Centers 2022

No abstract provided.

An Evaluation Of Oral Anticoagulation Initiation After Ischemic Stroke In Patients With Atrial Fibrillation/Atrial Flutter At Hospital Discharge, Jessica Zhao, Meri Slavica, Vanessa Jenkins, Natalie Swearingen

Providence Pharmacy PGY1 Program at Providence Portland and Providence St. Vincent Medical Centers 2022

No abstract provided.

Evaluating The Impact Of Ambulatory Care Clinical Pharmacy Services In The Pediatric Population, Sheila Prabhu, Bonnie Jiron, Vivian Tang

Providence Pharmacy PGY2 Program at Providence Medical Group 2022

No abstract provided.

Evaluation Of Infusion Reactions Associated With Intravenous Immune Globulin (Ivig) In Neonatal And Pediatric Patients, Katie Couch, Samantha Tatz

Providence Pharmacy PGY1 Program at Providence Portland and Providence St. Vincent Medical Centers 2022

No abstract provided.

Evaluation Of A Beta-Lactam Antibiotic Allergy Assessment Tool For Patients Receiving Surgical Prophylaxis, Katelynn Tran, Alyssa B Christensen, Tobias Pusch, Jennifer Marfori

Providence Pharmacy PGY1 Program at Providence Portland and Providence St. Vincent Medical Centers 2022

No abstract provided.

Preoperative Phytonadione Supplementation For Mitral Valve Intervention Hemostasis, Katherine M. Nguyen, Joshua Francis, Celine Munoz, Torin P. Fitton

Providence Pharmacy PGY1 Program at Providence Portland and Providence St. Vincent Medical Centers 2022

No abstract provided.

Protocol Analysis Of An Antimicrobial Renal Dose Protocol At A Large, Tertiary Medical Center, Nicole Hulsebus, Meagan Greckel, Brent Footer

Providence Pharmacy PGY1 Program at Providence Portland and Providence St. Vincent Medical Centers 2022

No abstract provided.

Evaluation Of Pharmacist-Led Transitions Of Care (Toc) Discharge Pilot Program For Reducing 30-Day Readmission Rates In Patients With Chronic Obstructive Pulmonary Disease (Copd, Ann Tong, Hyesoo Chae, Addison Pang, Tony Lucchi

Providence Pharmacy PGY1 Program at Providence Portland and Providence St. Vincent Medical Centers 2022

No abstract provided.

Impact Of Pharmacist Led Provider Education On Outpatient Copd Management, Erica Dominguez, Ben Rosati, Trevor Laursen

Providence Pharmacy PGY2 Program at Providence Medical Group 2021

Purpose

To evaluate the efficacy of provider education on adherence to guideline directed therapy in outpatient chronic obstructive pulmonary disease (COPD) management in South Oregon PMG clinics.

Background

• COPD is the third most common cause of death in the US • The CDC reports costs attributable to COPD in 2010 were $32.1 billion projected to have increased to $49 billion by 2020 • Direct healthcare costs include detection, prevention, physician office visits, hospitalizations, home care, and medications hospitalizations accounting for about 45 50% of these direct costs • Clinical burden of uncontrolled COPD has been shown to impact quality …

Assessing The Effect Of An Electronic Health Record Order Entry Guideline On Duration Of Outpatientantimicrobial Therapy Prescribed For Uncomplicated Urinary Tract Infections, Kasey Rubin, Chelsea Houshour, Christine Doran

Providence Pharmacy PGY2 Program at Providence Medical Group 2021

Background

• Fifty percent of antibiotics prescribed in the outpatient setting are unnecessary1. •Outside of unnecessary prescribing, the antibiotics chosen can be incorrect with an inappropriate duration of therapy1. •It has been estimated that resistant infections affect nearly 3 million Americans annually and are the cause of 35,000 deaths each year with added costs up to $33.2 billion dollars1. •The Centers for Disease Control (CDC) recommends that outpatient antimicrobial stewardship programs identify “high priority conditions.” •Examples of high priority conditions include acute respiratory infections, urinary tract infections (UTI)and skin and soft tissue infections (SSTI).2 •Antibiotics are not associated with a …

Evaluation Of Clinical Pharmacist Management Trends For Depression, Adam Olesen, Kelsie Fiss, Judy Wong

Providence Pharmacy PGY2 Program at Providence Medical Group 2021

Background

• Depression affects almost 10 of Americans over 18 years old 1 • Per the Centers for Disease and Control Prevention, the 2020 COVID 19 pandemic has led to an increase in adults struggling with mental health 1 • There is currently a shortage of mental health prescribers, with over half of all counties within the United States not having a single psychiatrist 2 • Southern Oregon also has a shortage of mental health prescribers, resulting in longer wait times for care • Evidence demonstrates that depression managed by pharmacists in the primary care setting led to increased follow …

Optimizing The Role Of Clinical Pharmacy Services In Transitions Of Care, Dj Clark, Clara Mikhaeil, Karen White

Providence Pharmacy PGY2 Program at Providence Medical Group 2021

Purpose

Health & Services The purpose of this project is to improve clinical outcomes in patients transitioning from inpatient to outpatient care by optimizing the process that primary care pharmacists use to perform comprehensive medication reviews.

Background

• Transitions of care from the inpatient to outpatient setting is an area of great opportunity for improving patient outcomes. • One prospective cohort study found that 20% of patients discharged from the hospital to home experienced an adverse event within 3 weeks of discharge. Of these adverse events, 66% were medication related.1 • Another observational study found that 14% of patients had …